| Joel Juarez-uribe, MD | |
|
750 Medical Center Ct Ste 14, Chula Vista, CA 91911-6634 | |
| (619) 421-1228 | |
| (619) 421-3895 |
| Full Name | Joel Juarez-uribe |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 51 Years |
| Location | 750 Medical Center Ct Ste 14, Chula Vista, California |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912091067 | NPI | - | NPPES |
| 00A405710 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | C40571 (California) | Primary |
| Entity Name | Emergency And Acute Care Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437103942 PECOS PAC ID: 9537108279 Enrollment ID: O20050502000734 |
News Archive
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases such as Alzheimer's disease (AD), announced today the detection of the AD-associated aggregated Beta-amyloid (ABeta), the hallmark of AD, in the blood from the most-frequently-used animal model of AD. The assay detects both oligomeric and fibrillar aggregates of ABeta, which are generally considered to be the toxic forms and major contributors to brain dysfunction in AD.
Although health officials say they have no reason to expect any unusual problems with the vaccine that will likely be available next month, the government is establishing an extensive tracking system to watch for possible side effects, the Associated Press/Washington Post report.
Tobacco use causes a field of precancerous cells, increasing the risk of developing head & neck cancer. But exactly how this precancerous field influences cancer has been often overlooked.
Despite the fact that an estimated 25 million patients per year in the U.S. undergo surgeries using general anesthesia, scientists have only been able to hypothesize exactly how anesthetics interact with the central nervous system. They previously thought that the processes of "going under" and waking up from anesthesia affected the brain in the same way.
GeneGo, Inc., the leading systems biology tools company, announced today that Proteostasis Therapeutics has licensed its data mining and analysis platform, MetaCore. Proteostasis Therapeutics is the first company dedicated to the discovery of novel small molecule therapeutics based upon understanding the body's Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joel Juarez-uribe, MD 750 Medical Center Ct Ste 14, Chula Vista, CA 91911-6634 Ph: (619) 421-1228 | Joel Juarez-uribe, MD 750 Medical Center Ct Ste 14, Chula Vista, CA 91911-6634 Ph: (619) 421-1228 |
News Archive
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases such as Alzheimer's disease (AD), announced today the detection of the AD-associated aggregated Beta-amyloid (ABeta), the hallmark of AD, in the blood from the most-frequently-used animal model of AD. The assay detects both oligomeric and fibrillar aggregates of ABeta, which are generally considered to be the toxic forms and major contributors to brain dysfunction in AD.
Although health officials say they have no reason to expect any unusual problems with the vaccine that will likely be available next month, the government is establishing an extensive tracking system to watch for possible side effects, the Associated Press/Washington Post report.
Tobacco use causes a field of precancerous cells, increasing the risk of developing head & neck cancer. But exactly how this precancerous field influences cancer has been often overlooked.
Despite the fact that an estimated 25 million patients per year in the U.S. undergo surgeries using general anesthesia, scientists have only been able to hypothesize exactly how anesthetics interact with the central nervous system. They previously thought that the processes of "going under" and waking up from anesthesia affected the brain in the same way.
GeneGo, Inc., the leading systems biology tools company, announced today that Proteostasis Therapeutics has licensed its data mining and analysis platform, MetaCore. Proteostasis Therapeutics is the first company dedicated to the discovery of novel small molecule therapeutics based upon understanding the body's Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases.
› Verified 3 days ago
Dr. Perry V Montoya, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 525 3rd Ave, Chula Vista, CA 91910 Phone: 858-499-2600 Fax: 619-585-4353 | |
John S Videen, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 752 Medical Center Ct, Suite 302, Chula Vista, CA 91911 Phone: 619-421-3361 Fax: 619-656-8936 | |
Daniel Cepin, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 890 Eastlake Pkwy, Suite 205, Chula Vista, CA 91914 Phone: 619-482-0300 Fax: 619-482-0959 | |
Kenneth Burton Johnson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 769 Medical Center Ct, Suite 202, Chula Vista, CA 91911 Phone: 619-482-8430 Fax: 619-482-8005 | |
Dr. Michael Sonbaty, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 E Palomar St, Chula Vista, CA 91913 Phone: 858-499-2616 | |
Sara Khandan, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 835 Third Ave Ste A, Chula Vista, CA 91911 Phone: 619-425-7755 Fax: 619-425-2138 | |
Alejandro G Hinojosa, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 340 4th Ave, Suite 8, Chula Vista, CA 91910 Phone: 619-216-7546 Fax: 619-216-7783 |